Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 11:00 save search
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
Published: 2024-04-19 (Crawled : 11:00) - globenewswire.com
PRQR | News | $1.965 5.65% 5.34% 130K
|
Health Technology
|
| O: -1.04%
H: 8.95%
C: 4.74%
defense
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CERE | $42.15 0.02% 0.02% 810K
|
Finance
|
| O: 0.78%
H: 0.0%
C: 0.0%
disease positive for topline parkinson’s trial therapeutics results living
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CMMB | $0.691 -1.29% -1.3% 15K
|
Manufacturing
|
| O: -3.38%
H: 0.0%
C: 0.0%
ccl24 disease association publication sclerosis
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
SWTX | $40.075 -5.64% -5.98% 1.4M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
first report therapeutics financial results
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: -0.43%
H: 4.57%
C: 0.0%
cd20 briumvi contract sclerosis for therapeutics
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
CGEM | $15.66 -13.29% -15.33% 1.2M
|
|
| O: 15.52%
H: 3.77%
C: -12.83%
expansion therapeutics
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
MRZM | $0.095 1031.22% 2.2K
|
Information
|
| O: 0.0%
H: 72.73%
C: 72.73%
QLGN | $0.301 -3.43% -3.55% 30K
|
Health Technology
|
| O: -4.91%
H: 3.23%
C: -3.29%
for commercialization therapeutics agreement
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
VYGR | $7.5 -0.66% -0.67% 520K
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: -4.77%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 3.13%
H: 0.38%
C: -2.68%
NBIX M | $132.03 -0.39% -0.39% 560K
|
Health Technology
|
| O: -2.15%
H: 2.58%
C: 0.92%
candidate payment for collaboration program therapeutics milestone
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
CGEM | $15.66 -13.29% -15.33% 1.2M
|
|
| O: 15.52%
H: 3.77%
C: -12.83%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 2.98%
H: 0.0%
C: 0.0%
million therapeutics
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
FHTX | $5.335 -3.53% -3.66% 120K
|
Health Technology
|
| O: -14.72%
H: 0.08%
C: -2.74%
therapeutics financial
Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
AXSM | $67.91 3.33% 3.22% 890K
|
Health Technology
|
| O: -3.37%
H: 0.83%
C: -0.76%
neurology meeting therapeutics
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
NMRA | $10.18 -3.51% -3.63% 780K
|
|
| O: -20.17%
H: 11.46%
C: 0.99%
nmra-266 therapeutics study
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
APLT A | $4.4 -7.17% -7.73% 2.9M
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.69%
commercial therapeutics
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
IPSC | $3.06 2.86% 2.78% 110K
|
Professional, Scientific, and T...
|
| O: 3.39%
H: 11.53%
C: 2.02%
disease million pipeline acquisition expansion therapeutics
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 0.13%
H: 0.52%
C: 0.47%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 0.39%
H: 0.0%
C: -0.23%
ELYM | $3.82 -8.61% -9.42% 450K
|
|
| O: 49.44%
H: 0.0%
C: 0.0%
million acquire therapeutics agreement
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
UNCY | $1.08 -0.92% -0.93% 230K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.0%
C: -1.52%
conference therapeutics growth
BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
BTAI | $2.77 8.63% 7.94% 620K
|
Health Technology
|
| O: 0.96%
H: 1.9%
C: 0.0%
bxcl501 alzheimer’s dementia for trial therapeutics
Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
AXSM | $67.91 3.33% 3.22% 890K
|
Health Technology
|
| O: -2.66%
H: 1.26%
C: 0.37%
first report therapeutics financial results
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: 18.35%
H: 1.98%
C: -5.88%
first update therapeutics financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.